Birgitte Rono

Horsholm, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Correction: APC-targeted DNA vaccines: the role of CCL19 in immune cell recruitment and early onset of the immune response.

Correction: APC-targeted DNA vaccines: the role of CCL19 in immune cell recruitment and early onset of the immune response.

Journal: Cancer immunology, immunotherapy : CII

Published: July 11, 2026

APC-targeted DNA vaccines: the role of CCL19 in immune cell recruitment and early onset of the immune response.

APC-targeted DNA vaccines: the role of CCL19 in immune cell recruitment and early onset of the immune response.

Journal: Cancer immunology, immunotherapy : CII

Published: September 08, 2025

Preclinical evaluation of a CCL19 immune-potentiated DNA cancer vaccine.

Preclinical evaluation of a CCL19 immune-potentiated DNA cancer vaccine.

Journal: Cancer immunology, immunotherapy : CII

Published: March 31, 2025

Endogenous viral elements constitute a complementary source of antigens for personalized cancer vaccines.

Endogenous viral elements constitute a complementary source of antigens for personalized cancer vaccines.

Journal: NPJ vaccines

Published: October 03, 2024

Refined analytical pipeline for the pharmacodynamic assessment of T-cell responses to vaccine antigens.

Refined analytical pipeline for the pharmacodynamic assessment of T-cell responses to vaccine antigens.

Journal: Frontiers in immunology

Published: March 20, 2024

Corrigendum: Targeting neoantigens to APC-surface molecules improves the immunogenicity and anti-tumor efficacy of a DNA cancer vaccine.

Corrigendum: Targeting neoantigens to APC-surface molecules improves the immunogenicity and anti-tumor efficacy of a DNA cancer vaccine.

Journal: Frontiers in immunology

Published: September 07, 2023

Targeting neoantigens to APC-surface molecules improves the immunogenicity and anti-tumor efficacy of a DNA cancer vaccine.

Targeting neoantigens to APC-surface molecules improves the immunogenicity and anti-tumor efficacy of a DNA cancer vaccine.

Journal: Frontiers in immunology

Published: June 05, 2023

DNA immunization with in silico predicted T-cell epitopes protects against lethal SARS-CoV-2 infection in K18-hACE2 mice.

DNA immunization with in silico predicted T-cell epitopes protects against lethal SARS-CoV-2 infection in K18-hACE2 mice.

Journal: Frontiers in immunology

Published: February 15, 2023

DNA based neoepitope vaccination induces tumor control in syngeneic mouse models.

DNA based neoepitope vaccination induces tumor control in syngeneic mouse models.

Journal: NPJ vaccines

Published: September 23, 2022

Antibody-Mediated Neutralization of uPA Proteolytic Function Reduces Disease Progression in Mouse Arthritis Models.

Antibody-Mediated Neutralization of uPA Proteolytic Function Reduces Disease Progression in Mouse Arthritis Models.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: September 15, 2017

Simultaneous targeted activation of Notch1 and Vhl-disruption in the kidney proximal epithelial tubular cells in mice.

Simultaneous targeted activation of Notch1 and Vhl-disruption in the kidney proximal epithelial tubular cells in mice.

Journal: Scientific reports

Published: January 26, 2016

Rapid-onset clinical and mechanistic effects of anti-C5aR treatment in the mouse collagen-induced arthritis model.

Rapid-onset clinical and mechanistic effects of anti-C5aR treatment in the mouse collagen-induced arthritis model.

Journal: Clinical and experimental immunology

Published: March 13, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026